3 Results for "

2D plates

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "2D plates" in MCE Product Catalog:

RWJ52353 hydrochloride
RWJ52353 hydrochloride
0 Images
Cat. No.: HY-103216A
CAS No.: 245744-13-2
Target:  

Adrenergic Receptor

Research Areas:  

Neurological Disease

RWJ-52353 hydrochloride is an orally potent, highly selective α2D adrenergic receptor agonist (Ki: 1.5 nM) with potential analgesic effects. RWJ-52353 hydrochloride demonstrated analgesic activity in abdominal tests in rats and mice, and improved agitation in mice in the hot plate test and tail flick test. RWJ-52353 hydrochloride also regulates the organic cation transporter (OCT) subtype, inhibiting rOCT1 and rOCT2 with IC50s of 100 μM and 20 μM respectively; it also activates rOCT3, affecting [3H]-1- in cells. Methyl-4-phenylpyridinium ([3H]MPP) transport .
loading...
    loading...
View All Sizes
Cyclo(L-Ile-L-Ala)
Cyclo(L-Ile-L-Ala)
0 Images
Cat. No.: HY-N9251A
CAS No.: 35590-69-3
Target:  

Inhibitory Antibodies

Research Areas:  

Others

Cyclo (L-Ile-L-Ala) is a cyclic dipeptide (2,5-diketopiperazine). Cyclo (L-Ile-L-Ala) self-assembles into ordered two-dimensional lamellae in hexafluoroisopropanol; increasing concentrations lead to the formation of larger, more complex lamellae. Cyclo (L-Ile-L-Ala) self-assembles into fibrous structures in methanol, and its self-assembly process is sensitive to solvent conditions and building block concentrations .
loading...
    loading...
View All Sizes
FDA-Approved Drug Library Mini
FDA-Approved Drug Library Mini
0 Images
Cat. No.: HY-L022M
3,236 compounds

New drug development is a time-consuming and high-cost process. Drug repurposing (also called drug repositioning, reprofiling or re‑tasking) offers various advantages over developing an entirely new drug for a given indication. First, the risk of failure is lower. Second, the time frame for drug development can be reduced. Third, less investment is needed. Approved drugs have identified bioactivities, good pharmacokinetic characteristics and safety which are suitable for drug repurposing.

MCE owns a unique collection of 3,236 approved compounds which have been completed extensive preclinical and clinical studies and have well-characterized bioactivities, safety and bioavailability properties. The package of this library is 96-well microplate with peelable foil seal, which makes the screening process easier and faster.

Assay Types